ArticleJournal of cancer survivorship : research and practice2025
'I knew I had to drive my own bus': perspectives of patients and healthcare professionals on improving information provision to rare cancer survivors.
Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rare prostate cancer histologies: detection, characteristics and treatment.Nature reviews. Urology · 2026Review
- "The uncharted waters of completely not knowing what's next": rare cancer patients' experiences regarding navigating uncertainty.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePeople diagnosed with a rare cancer report a high need for information. Research on rare cancer survivors' preferences for, and challenges in, accessing information is scarce. The aims of this study were to explore the following: (1) rare cancer patients' preferences for information content and delivery mode and (2) the experiences of healthcare professionals in delivering information to this patient group.
methodsInterviews with rare cancer survivors and healthcare professionals were conducted between October 2023 and June 2024. Semi-structured interview guides were developed for both survivors and professionals. Interviews were recorded, transcribed verbatim and analysed using thematic analysis.
resultsA total of 32 interviews (20 survivors and 12 healthcare professionals) were undertaken. Four themes were generated: (1) 'Questions need to be addressed regardless of information availability', (2) 'Information seeking is a fundamental part of the rare cancer experience' , (3) 'Healthcare professionals are responsible for information sharing' and (4) 'Tailoring information to patient preferences is a balancing act'.
conclusionThis study highlights the importance of providing tailored, relevant information to rare cancer survivors in a face-to-face format, despite there being a paucity of information available on many rare cancers. Survivors highlighted the importance of their role in sourcing information and advocating for themselves, whereas health professionals identified their responsibility for providing tailored information to their patients. IMPLICATIONS FOR CANCER SURVIVORS: The findings suggest a need to improve how information is structured and delivered to rare cancer survivors to ensure their unique needs and questions are adequately addressed.
Indexed as
Identifiers
40971143What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.